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1. Introduction
Extemporaneous preparation 
of medical products is currently 
a very relevant topic and can be 
considered from the perspective 
of development of the Ukrainian 
pharmaceutical field. The concept 
of personal drugs is aimed at pro-
viding effective individual phar-
macotherapy [1]. During military 
actions in Ukraine, the problem 
of drug production remains im-
portant in the system of medical 
assistance for disaster medicine 
and military medicine for a spe-
cial period. Recently in Ukraine 
there is a tendency of reducing the 
number of producing pharmacies.
This principle underlies Good 
Pharmaceutical practice and 
should be the main philosophy of 
specialists in the system of medi-
cal and pharmaceutical assistance 
to the population of Ukraine [2]. 
Save preparation of the medicinal 
drugs in pharmacies is an import-
ant task of pharmaceutical science 
and practice. Mainly scientific re-
searches are devoted to organiza-
tional and economic problems of 
drug production in pharmacies. 
Our research is more focused on 
the problem of extemporaneous 
preparation of medicinal prod-
ucts as an important element of 
pharmaceutical service to the 
population, which is of particular 
relevance during the period of 
emergencies and military actions 
in Ukraine.
Therefore, in connection with the above, the purpose of the 
study was to establish trends in the development of preparation 
of medicines in pharmacies, analyze the factors, affecting the 
state of drug manufacturing in pharmacies of Ukraine and the 
study of possible ways of further development of this type of 
pharmaceutical assistance.
2. Methods
The methodological basis of the study was a systemic ap-
proach, which makes it possible to identify the main tendences 
for the extemporaneous preparation of medicinal products in 
Ukraine and in foreign countries. We used also comparative, 
documental, statistical analyzes, analytical review and a survey 
of pharmacy specialists. The materials of the study were the 
normative documents of the Ministry of Health of Ukraine, an-
alytical articles, scientific publications of Ukrainian and foreign 
authors, nomenclature of drugs in pharmacies.
3. Result
According to the results of the study, it was found, that due 
to the expansion of the assortment of ready-made medicines in 
Ukraine, the volume of products, manufactured under the con-
ditions of pharmacies, has significantly decreased over the past 
15 years, a significant number of pharmacies has refused to carry 
out this type of activity by com-
mencing a purely commercial sale 
of industrial production. On Janu-
ary 1, 2020, there were 16500 phar-
macies in Ukraine, but only 1.8 % 
of pharmacies with the function of 
preparation of medicines.
According to Fig. 1, there is a 
significant reduction in the num-
ber of manufacturing pharma-
cies in Ukraine, from 2004 to 
2020 years, the total number of 
pharmacies decreased by 77.3 %, 
more than three times. We con-
ducted a study of the factors, caus-
ing a significant decrease in the 
volumes of the extemporaneous 
drugs and the number of produc-
ing pharmacies in Ukraine. It is 
established, that the main factors 
are: imperfection of the legislative 
and legal documents of the phar-
maceutical field in Ukraine, the 
difficulty of obtaining a license 
for the preparation of drugs in 
pharmacies, problems with the 
registration of substances, the lack 
of an approved list of substances, 
auxiliary substances, pharmacy 
tableware, primary packaging ma- 
terials, allowed for use in produc-
ing pharmacies, short shelf-life 
of medicines, the absence of a 
regulated list of extemporaneous 
medicinal products, for which 
there are no industrial analogues, 
the slow introduction of Good 
Pharmaceutical Practice in phar-
macies [3, 4].
Fig. 1. Comparative analysis of the number of  
pharmacies with extemporaneous preparation of medicines  
in Ukraine
The analysis of the world practice in the preparation of 
medicinal products in pharmacies shows that in most countries 
of different continents’ pharmacies produced medicines in hos-
pital pharmacies, that is, the classical traditions of an individual 
approach to providing the population with medicines remain 
with the pharmacy [5, 6]. In economically developed countries 
there are quite a large number of pharmacies with preparation 
of sterile and non-sterile drugs according to individual prescrip-
tions, including parenteral nutrition mixtures, as well as drugs 
for clinical trials (Table 1).
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Table 1
The prepation of medicinal products in pharmacies in the world
















In European countries and foreigh countries, producing 
pharmacies are seen as a way to meet the patient’s specific needs, 
and medicines, prepared at a pharmacy, are considered “per-
sonal drugs”. This production becomes relevant, when a drug is 
not available in the pharmaceutical market, in particular when 
there is no corresponding dosage form, dose or concentration 
of an active pharmaceutical ingredient, for example, there is no 
liquid or cream, but there are tablets or ointment, the patient’s 
sensitivity to the auxiliary substances that are present in the 
industrially manufactured medicine, or the problem of the dis-
crepancy between the taste of a drug, is observed [7, 8]. In this 
regard, it is important to study the experience of preparation of 
medicines in pharmacies in the world’s leading countries. All 
over the world it is recognized, that medicines are made by the 
hands of a pharmacist much more efficiently than analogues 
of industrial manufacturing.The absence of synthetical phar-
maceutical agents, such as preservatives, dye and stabilizers is 
the main advantage of medicinal products, made at pharmacies 
over commercially manufactured pharmaceuticals [9, 10]. 
The next step was to study the nomenclature of drugs in 
terms of the pharmacological focus of producing pharmacies 
in Ukraine. The data obtained indicate that the most common 
are extemporaneous medicines for using in pediatrics, neurol-
ogy, allergology and dermatology. The study in the producing 
pharmacies showed that liquid medical forms (mixtures, eye 
drops, sterile solutions) make up 68.5 %, solid medical forms 
(powders) – 9.4 % and soft medical forms (ointments, pastes) – 
22.1 %. When studying the preparation of drugs in pharmacies, 
there have been identified medicines that have no industrial 
analogues. The existing assortment of medicines of industrial 
production can not fill the whole range of medicines, especially 
since there are such medicines that are not manufactured by 
industry for different reasons. 
4. Discussion
Preparation of drugs in pharmacies remains relevant today, 
especially for hospitals, because there is an existing range of 
drugs for industrial production that cannot fill all the required 
spectrum of drugs for patients, especially since there are no 
ones, produced by industry for various reasons. These include: 
solutions for internal use by newborns, oxidizing solutions, 
dosage forms of colloidal preparations of silver, electrophoresis 
solutions, sterile solutions for external use, еxtemporaneous 
medicines, made in field pharmacies.
The first group is sterile solutions for internal use by new-
borns. Glucose solutions 5, 10, 25 % – are prepared for new-
borns without a stabilizer. The shelf life of glucose solutions 
for newborns is only 1 month. There is no industrial analogue 
of solutions of glucose 10 % or 20 % 100.0, glutamic acid – 1.0. 
Dibazole solutions are also unsuitable for internal use in the 
treatment of newborns, because the factory preparation con-
tains hydrochloric acid. Potassium iodide solution 0.5 % – no 
industrial analogue. Ascorbic acid solution of 1 % – the finished 
dosage form is available only in ampoules and is the sodium salt 
of ascorbic acid. At that it contains an antioxidant that cannot 
be used for newborns. There are also no industrial analogues of 
1 % of glutamic acid and hydrogen chloride acid solutions. Thus, 
only producing pharmacies meet the needs of maternity hos-
pital compartments in solutions for internal use by newborns.
The next group of drugs is oxidizing solutions: potassium 
permanganate solutions, used in concentrations – 5 % for neona-
tal cord processing; 2–5 % – for lubrication of ulcerative and burn 
surfaces; 0.2–0.1 % – in gynecological and urological practice. 
The highest value is currently 0.05 % potassium permanganate 
solution, which is an integral part of all medical staff workplaces. 
The next group is solutions for electrophoresis. Electro-
phoresis is widely used in many health and care institution. 
Electrophoresis requires aqueous drug solutions substances: 
metamizole sodium, dibazole, dimedrol, papaverine, ichthyol, 
zinc sulfate, potassium chloride and many others. However, 
the preservatives can not be used because of their electrical 
non-indifference. Today suitable industrial dosage forms for 
electrophoresis do not exist. 
Another group is drugs of silver. They are used in the form 
of colloidal solutions for cavity washes and many other proce-
dures – protargol solution 1 %, 2 %, 3.5 %. Oother important 
moments are: production of pediatric and geriatric medicines, 
practically nonexistent both in composition and dosage; man-
ufacture of inexpensive eye drops, including those without 
preservatives, used after surgery. 
The advantage of preparation of medicinal products in 
pharmacies over industrial drugs production is the absence of 
synthetic auxiliaries, including: preservatives, used to prevent 
microbial contamination during long – term storage, dyes to 
provide an attractive exterior appearance, fillers, needed to 
give shape (tablets, pills, pellets, etc.), stabilizers – to prevent 
the chemical reactions, leading to the formation of toxic or in-
active decomposition products, reduction of the likelihood of 
allergic reactions to individual drugs, medicines of individual 
preparation practically do not cause addiction, 100 % no risk 
of falsification of the medicinal product, individual selection 
of a drug composition and dosage, lower price, compared with 
industrial drug due to the lack of storage, shipping, advertising 
and commercial promotion of the drug, lack of registration 
procedure for medicines that provides time and cost savings, 
possibility of making small batches of medicines on the re-
quirements and requests of hospitals, polyclinics and other 
medical institutions. 
The conducted research shows that preparation of medi-
cines in pharmacies is necessary to ensure the special needs 
of an individual patient. The results of the study suggest 
possible ways to optimize the preparation of medicinal 
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products in pharmacies of Ukraine: creation of a separate de-
partment at the Ministry of Health, which would coordinate 
interaction of all links in solving issues of extemporaneous 
production of drugs, solving the issue of procurement of 
substances, creating electronic bases of reference literature 
on organization, technology and analysis of extemporaneous 
preparation of drugs, use of modern logistics technologies for 
the delivery of extemporaneous medicines, program develop-
ment of the revival of the extemporaneous preparation as a 
state social project.
Preparation of medicinal products in pharmacies is social-
ly relevant and it is actual for today in Ukraine. In modern 
conditions, the importance of health is being significantly re-
thought in the light of its understanding as an integral human 
right, in terms of existing threats and challenges, increasing 
demands for quality of health, technological and financial 
capabilities of its provision. Preparation of medicinal products 
in pharmacies meets the specified requirements, provides 
individuals with a dual approach to a patient and can also be 
used during the period of emergencies and military actions.
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